Overview
Cerebrae provides financial solutions for the healthcare industry through a subscription platform that helps healthcare providers and insurers manage financial risk and opportunities in value-based care (VBC). Its suite includes pricing, underwriting, contracting, and actuarial analytics to track savings, monitor performance over time, and build ROI models. The platform enables clients to tailor VBC strategies, map expected utilization to contracts to evaluate profit and loss, and assess the financial risk and potential of risk-sharing revenue models. Cerebrae differentiates itself by focusing on the healthcare sector and VBC-specific financial tooling, offering an integrated, contract-aware toolkit that speeds up deal diligence and financial planning. The company’s goal is to help healthcare organizations optimize financial performance and manage risk as they transition to value-based care.
Work here?Claim your company
Simplify's take
What believers are saying
- Accorded raised roughly $16.5 million by December 2021, funding product development.
- Built In San Francisco listed 28 employees in October 2026, signaling operating continuity.
- Sonrava Health used Cerebrae for employee benefits design, validating customer demand.
What critics are saying
- Octave announced Cerebrae acquisition on November 11, 2026, ending standalone status.
- Product overlap inside Octave threatens Cerebrae's roadmap and team retention by 2027.
- Healthcare contracting software faces long sales cycles and easy incumbent displacement.
What makes Cerebrae unique
- Cerebrae became Accorded in 2022, focused on value-based contracting analytics.
- Its actuarial workflow translated claims data into contract-ready financial models.
- It served providers, employers, and payers with pricing, underwriting, and ROI tools.
Help us improve and share your feedback! Did you find this helpful?